Amphetamine up-regulates activator of G-protein signaling 1 mRNA and protein levels in rat frontal cortex: the role of dopamine and glucocorticoid receptors

Neuroscience

Volumn 168, Issue 1, 2010, Pages 96-107

  Schwendt, M ^a   McGinty, J F ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Amphetamine; Dopamine receptor; Frontal cortex; G protein; Glucocorticoid receptor

Indexed keywords

ACTIVATOR OF G PROTEIN SIGNALING 1 PROTEIN; AMPHETAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; PROTEIN AGS1; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; GENE EXPRESSION; HISTOCHEMISTRY; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; UPREGULATION;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FRONTAL LOBE; MALE; RAS PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; UP-REGULATION;

EID: 77952891993     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.03.013     Document Type: Article

References (73)

1. Alonso R., Voutsinos B., Fournier M., Labie C., Steinberg R., Souilhac J., Le Fur G., Soubrié P. Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function. Neuroscience 1998, 91:607-620.
2. Alttoa A., Eller M., Herm L., Rinken A., Harro J. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus. Brain Res 2007, 1131:138-148.
3. Ammon-Treiber S., Tischmeyer H., Riechert U., Hollt V. Gene expression of transcription factors in the rat brain after morphine withdrawal. Neurochem Res 2004, 29:1267-1273.
4. Bailey A., Metaxas A., Yoo J.H., McGee T., Kitchen I. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm. Eur J Neurosci 2008, 28:759-770.
5. Blumer J.B., Cismowski M.J., Sato M., Lanier S.M. AGS proteins: receptor-independent activators of G-protein signaling. Trends Pharmacol Sci 2005, 26:470-476.
6. Bonhomme N., Cador M., Stinus L., Le Moal M., Spampinato U. Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study. Brain Res 1995, 675:215-223.
7. Borgkvist A., Fisone G. Psychoactive drugs and regulation of the cAMP/PKA/DARPP-32 cascade in striatal medium spiny neurons. Neurosci Biobehav Rev 2007, 31:79-88.
8. Borowsky B., Kuhn C.M. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats. Neuropharmacology 1992, 31:671-678.
9. Bowers M.S., Hopf F.W., Chou J.K., Guillory A.M., Chang S.J., Janak P.H., Bonci A., Diamond I. Nucleus accumbens AGS3 expression drives ethanol seeking through G betagamma. Proc Natl Acad Sci U S A 2008, 105:12533-12538.
10. Bowers M.S., McFarland K., Lake R.W., Peterson Y.K., Lapish C.C., Gregory M.L., Lanier S.M., Kalivas P.W. Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking. Neuron 2004, 42:269-281.
11. Brogan M.D., Behrend E.N., Kemppainen R.J. Regulation of Dexras1 expression by endogenous steroids. Neuroendocrinology 2001, 74:244-250.
12. Burchett S.A., Bannon M.J., Granneman J.G. RGS mRNA expression in rat striatum: modulation by dopamine receptors and effects of repeated amphetamine administration. J Neurochem 1999, 72:1529-1533.
13. Cabrera-Vera T.M., Hernandez S., Earls L.R., Medkova M., Sundgren-Andersson A.K., Surmeier D.J., Hamm H.E. RGS9-2 modulates D2 dopamine receptor-mediated Ca2+ channel inhibition in rat striatal cholinergic interneurons. Proc Natl Acad Sci U S A 2004, 101:16339-16344.
14. Cismowski M.J. Non-receptor activators of heterotrimeric G-protein signaling (AGS proteins). Semin Cell Dev Biol 2006, 17:334-344.
15. Cole A.J., Bhat R.V., Patt C., Worley P.F., Baraban J.M. D1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J Neurochem 1992, 58:1420-1426.
16. Daunais J.B., McGinty J.F. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse 1994, 18:35-45.
17. De Vries T.J., Schoffelmeer A.N., Tjon G.H., Nestby P., Mulder A.H., Vanderschuren L.J. Mifepristone prevents the expression of long-term behavioural sensitization to amphetamine. Eur J Pharmacol 1996, 307:R3-R4.
18. Fang M., Jaffrey S.R., Sawa A., Ye K., Luo X., Snyder S.H. Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 2000, 28:183-193.
19. Fujiyama K., Kajii Y., Hiraoka S., Nishikawa T. Differential regulation by stimulants of neocortical expression of mrt1, arc, and homer1a mRNA in the rats treated with repeated methamphetamine. Synapse 2003, 49:143-149.
20. Fumagalli F., Bedogni F., Frasca A., Di Pasquale L., Racagni G., Riva M.A. Corticostriatal up-regulation of activity-regulated cytoskeletal-associated protein expression after repeated exposure to cocaine. Mol Pharmacol 2006, 70:1726-1734.
21. Fumagalli F., Bedogni F., Maragnoli M.E., Gennarelli M., Perez J., Racagni G., Riva M.A. Dopaminergic D2 receptor activation modulates FGF-2 gene expression in rat prefrontal cortex and hippocampus. J Neurosci Res 2003, 74:74-80.
22. Gaspar P., Bloch B., Le Moine C. D1 and D2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur J Neurosci 1995, 7:1050-1063.
23. Geurts M., Hermans E., Maloteaux J.M. Opposite modulation of regulators of G protein signalling-2 RGS2 and RGS4 expression by dopamine receptors in the rat striatum. Neurosci Lett 2002, 333:146-150.
24. Ghasemzadeh M.B., Windham L.K., Lake R.W., Acker C.J., Kalivas P.W. Cocaine activates Homer1 immediate early gene transcription in the mesocorticolimbic circuit: differential regulation by dopamine and glutamate signaling. Synapse 2009, 63:42-53.
25. Gonzalez-Nicolini V., McGinty J.F. Gene expression profile from the striatum of amphetamine-treated rats: a cDNA array and in situ hybridization histochemical study. Brain Res Gene Expr Patterns 2002, 1:193-198.
26. Graham T.E., Prossnitz E.R., Dorin R.I. Dexras1/AGS-1 inhibits signal transduction from the Gi-coupled formyl peptide receptor to Erk-1/2 MAP kinases. J Biol Chem 2002, 277:10876-10882.
27. Graham T.E., Qiao Z., Dorin R.I. Dexras1 inhibits adenylyl cyclase. Biochem Biophys Res Commun 2004, 316:307-312.
28. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci U S A 1990, 87:6912-6916.
29. Kalivas P.W., Lalumiere R.T., Knackstedt L., Shen H. Glutamate transmission in addiction. Neuropharmacology 2009, 56(Suppl 1):169-173.
30. Karler R., Calder L.D., Thai D.K., Bedingfield J.B. The role of dopamine in the mouse frontal cortex: a new hypothesis of behavioral sensitization to amphetamine and cocaine. Pharmacol Biochem Behav 1998, 61:435-443.
31. Kemppainen R.J., Behrend E.N. Dexamethasone rapidly induces a novel ras superfamily member-related gene in AtT-20 cells. J Biol Chem 1998, 273:3129-3131.
32. Kemppainen R.J., Cox E., Behrend E.N., Brogan M.D., Ammons J.M. Identification of a glucocorticoid response element in the 3'-flanking region of the human Dexras1 gene. Biochim Biophys Acta 2003, 1627:85-89.
33. Kimple R.J., De Vries L., Tronchère H., Behe C.I., Morris R.A., Gist Farquhar M., Siderovski D.P. RGS12 and RGS14 GoLoco motifs are G alpha(i) interaction sites with guanine nucleotide dissociation inhibitor activity. J Biol Chem 2001, 276:29275-29281.
34. Knych E.T., Eisenberg R.M. Effect of amphetamine on plasma corticosterone in the conscious rat. Neuroendocrinology 1979, 29:110-118.
35. Kobayashi T., Washiyama K., Ikeda K. Modulators of G protein-activated inwardly rectifying K+ channels: potentially therapeutic agents for addictive drug users. Ann N Y Acad Sci 2004, 1025:590-594.
36. Le Foll B., Diaz J., Sokoloff P. A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning. Neuroreport 2005, 16:175-178.
37. Moro H., Sato H., Ida I., Oshima A., Sakurai N., Shihara N., Horikawa Y., Mikuni M. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats. Pharmacol Biochem Behav 2007, 87:56-64.
38. Morsink M.C., Van Gemert N.G., Steenbergen P.J., Joels M., De Kloet E.R., Datson N.A. Rapid glucocorticoid effects on the expression of hippocampal neurotransmission-related genes. Brain Res 2007, 1150:14-20.
39. Nguyen C.H., Watts V.J. Dexras1 blocks receptor-mediated heterologous sensitization of adenylyl cyclase 1. Biochem Biophys Res Commun 2005, 332:913-920.
40. Ni Y.G., Gold S.J., Iredale P.A., Terwilliger R.Z., Duman R.S., Nestler E.J. Region-specific regulation of RGS4 (regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies. J Neurosci 1999, 19:3674-3680.
41. Nordquist R.E., Vanderschuren L.J., Jonker A.J., Bergsma M., de Vries T.J., Pennartz C.M., Voorn P. Expression of amphetamine sensitization is associated with recruitment of a reactive neuronal population in the nucleus accumbens core. Psychopharmacology (Berl) 2008, 198:113-126.
42. Paxinos G., Watson C. The rat brain in sterotaxic coordinates 2007, Academic Press, San Diego.
43. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 1997, 25:192-216.
44. Rahman Z., Schwarz J., Gold S.J., Zachariou V., Wein M.N., Choi K.H., Kovoor A., Chen C.K., DiLeone R.J., Schwarz S.C., Selley D.E., Sim-Selley L.J., Barrot M., Luedtke R.R., Self D., Neve R.L., Lester H.A., Simon M.I., Nestler E.J. RGS9 modulates dopamine signaling in the basal ganglia. Neuron 2003, 38:941-952.
45. Ross E.M., Wilkie T.M. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 2000, 69:795-827.
46. Ruskin D.N., Marshall J.F. Amphetamine- and cocaine-induced fos in the rat striatum depends on D2 dopamine receptor activation. Synapse 1994, 18:233-240.
47. Schmidt E.D., Tilders F.J., Binnekade R., Schoffelmeer A.N., De Vries T.J. Stressor- or drug-induced sensitization of the corticosterone response is not critically involved in the long-term expression of behavioural sensitization to amphetamine. Neuroscience 1999, 92:343-352.
48. Schmidt E.D., Tilders F.J., Janszen A.W., Binnekade R., De Vries T.J., Schoffelmeer A.N. Intermittent cocaine exposure causes delayed and long-lasting sensitization of cocaine-induced ACTH secretion in rats. Eur J Pharmacol 1995, 285:317-321.
49. Schwendt M, Chandler LJ, Blumer JB, Lanier SM, McGinty JF (2005) Expression of activator of G-protein signaling AGS1/DexRas1 in the rat brain increases during development and in response to acute amphetamine. In: Program and abstracts of the Society for Neuroscience 33rd Annual Meeting, pp 342.2, Washington, DC.
50. Schwendt M., Gold S.J., McGinty J.F. Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors. J Neurochem 2006, 96:1606-1615.
51. Schwendt M, McGinty JF (2006) Repeated administration of amphetamine and/or amphetamine challenge causes a decrease of RGS4 expression in rat dorsal striatum and prefrontal cortex. In: Program and abstracts of the Society for Neuroscience 34th Annual Meeting, pp 690.610, Atlanta, GA.
52. Seeman P., McCormick P.N., Kapur S. Increased dopamine D2(high) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO. Synapse 2007, 61:263-267.
53. Selemon L.D., Begovic A., Goldman-Rakic P.S., Castner S.A. Amphetamine sensitization alters dendritic morphology in prefrontal cortical pyramidal neurons in the non-human primate. Neuropsychopharmacology 2007, 32:919-931.
54. Swerdlow N.R., Koob G.F., Cador M., Lorang M., Hauger R.L. Pituitary-adrenal axis responses to acute amphetamine in the rat. Pharmacol Biochem Behav 1993, 45:629-637.
55. Takahashi H., Umeda N., Tsutsumi Y., Fukumura R., Ohkaze H., Sujino M., van der Horst G., Yasui A., Inouye S.T., Fujimori A., Ohhata T., Araki R., Abe M. Mouse dexamethasone-induced RAS protein 1 gene is expressed in a circadian rhythmic manner in the suprachiasmatic nucleus. Brain Res Mol Brain Res 2003, 110:1-6.
56. Takesono A., Nowak M.W., Cismowski M., Duzic E., Lanier S.M. Activator of G-protein signaling 1 blocks GIRK channel activation by a G-protein-coupled receptor: apparent disruption of receptor signaling complexes. J Biol Chem 2002, 277:13827-13830.
57. Tan A., Moratalla R., Lyford G.L., Worley P., Graybiel A.M. The activity-regulated cytoskeletal-associated protein arc is expressed in different striosome-matrix patterns following exposure to amphetamine and cocaine. J Neurochem 2000, 74:2074-2078.
58. Taymans J.M., Leysen J.E., Langlois X. Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions. J Neurochem 2003, 84:1118-1127.
59. Taymans J.M., Kia H.K., Claes R., Cruz C., Leysen J., Langlois X. Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time. Eur J Neurosci 2004, 19:2249-2260.
60. Taymans J.M., Kia H.K., Langlois X. Activator of G protein signaling type 3 mRNA is widely distributed in the rat brain and is particularly abundant in the subventricular zone-olfactory bulb system of neural precursor cell proliferation, migration and differentiation. Neurosci Lett 2006, 391:116-121.
61. i-dependent signaling to modulate N-type (CaV22) calcium channels. Am J Physiol Cell Physiol 2008, 295:C1417-C1426.
62. Vaidyanathan G., Cismowski M.J., Wang G., Vincent T.S., Brown K.D., Lanier S.M. The Ras-related protein AGS1/RASD1 suppresses cell growth. Oncogene 2004, 23:5858-5863.
63. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 2000, 151:99-120.
64. Vanderschuren L.J., Schoffelmeer A.N., Mulder A.H., De Vries T.J. Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine. Psychopharmacology (Berl) 1999, 143:244-253.
65. Vargiu P., Morte B., Manzano J., Perez J., de Abajo R., Gregor Sutcliffe J., Bernal J. Thyroid hormone regulation of rhes, a novel Ras homolog gene expressed in the striatum. Brain Res Mol Brain Res 2001, 94:1-8.
66. Wang J.Q., McGinty J.F. Differential effects of D1 and D2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced up-regulation of zif/268 mRNA expression in rat forebrain. J Neurochem 1995, 65:2706-2715.
67. Wang J.Q., McGinty J.F. Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain. J Pharmacol Exp Ther 1995, 273:909-917.
68. Wang J.Q., McGinty J.F. D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine. Synapse 1996, 22:114-122.
69. Webb C.K., McCudden C.R., Willard F.S., Kimple R.J., Siderovski D.P., Oxford G.S. D2 dopamine receptor activation of potassium channels is selectively decoupled by Galpha-specific GoLoco motif peptides. J Neurochem 2005, 92:1408-1418.
70. Wolf M.E., Jeziorski M. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res 1993, 613:291-294.
71. Yao L., McFarland K., Fan P., Jiang Z., Inoue Y., Diamond I. Activator of G protein signaling 3 regulates opiate activation of protein kinase A signaling and relapse of heroin-seeking behavior. Proc Natl Acad Sci U S A 2005, 102:8746-8751.
72. Zhai H., Li Y., Wang X., Lu L. Drug-induced alterations in the extracellular signal-regulated kinase (ERK) signalling pathway: implications for reinforcement and reinstatement. Cell Mol Neurobiol 2008, 28:157-172.
73. Zhang K., Tarazi F.I., Baldessarini R.J. Dopamine D(4) receptors in rat forebrain: unchanged with amphetamine-induced behavioral sensitization. Neuroscience 2000, 97:211-213.